Inside Providence plan 340B rebate disruption details the system’s financial and operational readiness for the new federal rebate pilot program.

For more than 30 years, thanks to bipartisan congressional support, the 340B program has helped eligible hospitals stretch limited federal resources to reduce the price of outpatient pharmaceuticals ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Nonprofit hospitals and health clinics are alarmed about a change that's coming to federal drug purchasing discounts next ...

WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...

On July 31, 2025, the Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA) issued a 340B Drug Pricing Program notice (the “Notice”) announcing the launch of a ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

Illinois lawmakers must press pause on expanding the program until they can answer this basic question: Are 340B dollars helping patients, or just boosting hospital margins? Without transparency, we ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Some hospitals are buying life-saving medications for pennies, then charging low-income patients, including many with disabilities, hundreds of dollars for these drugs. They do it every day under a ...